100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
Previously searched by you
Test Bank for Abrams’ Clinical Drug Therapy: Rationales for Nursing Practice, 13th Edition (Frandsen, 2025), Chapter 1-61 | All ChaptersR317,26
Add to cart
abrams clinical drug therapy rationales for nursin
clinical drug therapy rationales for nursing prac
rationales for nursing practice 13th edition
abrams clinical drug therapy
Connected book
Book Title:
Author(s):
Edition:
ISBN:
Edition:
More summaries for
Test Bank - Abrams’ Clinical Drug Therapy: Rationales for Nursing Practice, 13th Edition (Frandsen, 2024)Newest Edition
Test Bank - Abrams’ Clinical Drug Therapy: Rationales for Nursing Practice, 13th Edition (Frandsen, 2025), Chapter 1-61 | All Chapters
TEST BANK - ABRAMS’ CLINICAL DRUG THERAPY: RATIONALES FOR NURSING PRACTICE, 13TH EDITION (FRANDSEN, 2025), CHAPTER 1-61 | ALL CHAPTERS
All for this textbook (14)
Written for
Abrams' Clinical Drug Therapy: Rationales for Nurs
Abrams' Clinical Drug Therapy: Rationales for Nurs
2
reviews
By: kristenpoulos • 3 weeks ago
By: GRADESOLUTIONS • 3 months ago
Seller
Follow
beststar
Reviews received
Content preview
TEST BANK Abrams' Clinical Drug Therapy: Rationales for Nursing Practice 13th Edition by Geralyn Frandsen, and Sandra Smith Pennington TABLE OF CONTENT Chapter 1: The Foundation of Pharmacology: Quality and Safety ................................ ................................ ....... 1 Chapter 2: Basic Concepts and Processes ................................ ................................ ................................ ........... 11 Chapter 3: Medication Administration and the Nursing Process of Drug Therapy ................................ ............ 20 Chapter 4: Pharmacology and the Care of Infants and Pediatric Patients ................................ .......................... 29 Chapter 5: Pharmacology and the Care of Adults and Geriatric Patients ................................ ........................... 40 Chapter 6: Pharmacology and the Care of Pregnant or Lactating Females ................................ ........................ 51 Chapter 7: Pharmacology and Female Health ................................ ................................ ................................ .... 61 Chapter 8: Pharmacology and Male Health ................................ ................................ ................................ ........ 71 Chapter 9: Drug Therapy for Coagulation Disorders ................................ ................................ ......................... 83 Chapter 10: Drug Therapy for Dyslipidemia ................................ ................................ ................................ ...... 93 Chapter 11: Drug Therapy for Hematopoietic Disorders ................................ ................................ ................. 103 Chapter 12: Drug Therapy: Immunizations ................................ ................................ ................................ ...... 113 Chapter 13: Drug Therapy to Decrease Immunity ................................ ................................ ............................ 123 Chapter 14: Drug Therapy for the Treatment of Cancer ................................ ................................ ................... 134 Chapter 15: Inflammation, Infection, and the Use of Antibacterial Agents ................................ ..................... 144 Chapter 16: Drug Therapy to Decrease Pain, Fever, and Inflammation ................................ ........................... 155 Chapter 17: Drug Therapy with Corticosteroids ................................ ................................ ............................... 165 Chapter 18: Drug Therapy With Beta -Lactam Antibacterial Agents ................................ ............................... 176 Chapter 19: Drug Therapy With Aminoglycosides and Fluoroquinolones ................................ ...................... 186 Chapter 20: Drug Therapy With Tetracyclines, Sulfonamides, and Urinary Antiseptics ................................ 197 Chapter 21: Drug Therapy With Macrolides and Miscellaneous Anti -Infective Agents ................................ . 208 Chapter 22: Drug Therapy for Tuberculosis and Mycobacterium avium Complex Disease ............................ 218 Chapter 23: Drug Therapy for Viral Infections ................................ ................................ ................................ 228 Chapter 24: Drug Therapy for Fungal Infections ................................ ................................ ............................. 239 Chapter 25: Drug Therapy for Parasitic Infections ................................ ................................ ........................... 249 Chapter 26: Drug Therapy for Hypertension ................................ ................................ ................................ .... 260 Chapter 27: Drug Therapy for Dysrhythmias ................................ ................................ ................................ ... 270 Chapter 28: Drug Therapy for Coronary Heart Disease ................................ ................................ ................... 280 Chapter 29: Drug Therapy for Shock and Hypotension ................................ ................................ ................... 290 Chapter 30: Drug Therapy for Heart Failure ................................ ................................ ................................ .... 300 Chapter 31: Drug Therapy for Nasal Congestion and Cough ................................ ................................ ........... 310 Chapter 32: Drug Therapy to Decrease Histamine Effects and Allergic Response ................................ ......... 321 Chapter 33: Drug Therapy for Asthma, Airway Inflammation, and Bronchoconstriction ............................... 331 Chapter 34: Drug Therapy for Fluid Volume Excess ................................ ................................ ....................... 342 Chapter 35: Nutritional Support Products, Vitamins, and Mineral Supplements ................................ ............. 353 Chapter 36: Drug Therapy for Weight Management ................................ ................................ ........................ 363 Chapter 37: Drugs Therapy for Peptic Ulcer Disease and Hyperacidity ................................ .......................... 373 Chapter 38: Drug Therapy for Nausea and Vomiting ................................ ................................ ....................... 383 Chapter 39: Drug Therapy for Constipation and Elimination Problems ................................ .......................... 393 Chapter 40: Drug Therapy for Diarrhea ................................ ................................ ................................ ............ 403 Chapter 41: Drug Therapy for Diabetes Mellitus ................................ ................................ ............................. 413 Chapter 42: Drug Therapy for Hyperthyroidism and Hypothyroidism ................................ ............................ 423 Chapter 43: Drug Therapy for Pituitary and Hypothalamic Dysfunction ................................ ......................... 433 Chapter 44: Drug Therapy to Regulate Calcium and Bone Metabolism ................................ .......................... 443 Chapter 45: Drug Therapy for Adrenal Cortex Disorders ................................ ................................ ................ 453 Chapter 46: Physiology of the Autonomic and Central Nervous Systems and Indications for the Use of Drug Therapy 463 Chapter 47: Drug Therapy for Myasthenia Gravis, Alzheimer Disease, and Urinary Retention ..................... 475 Chapter 48: Drug Therapy for Parkinson Disease, Urinary Spasticity, and Disorders Requiring Anticholinergic Drug Therapy ................................ ................................ ................................ ................................ ................................ ............. 486 Chapter 49: Drug Therapy With Opioids ................................ ................................ ................................ .......... 496 Chapter 50: Drug Therapy With Local Anesthetics ................................ ................................ ......................... 506 Chapter 51: Drug Therapy With General Anesthetics ................................ ................................ ...................... 514 Chapter 52: Drug Therapy for Migraines and other Headaches ................................ ................................ ....... 523 Chapter 53: Drug Therapy for Seizure Disorders and Skeletal Muscle Relaxants ................................ ........... 532 Chapter 54: Drug Therapy for Anxiety and Insomnia ................................ ................................ ...................... 541 Chapter 55: Antidespressants and Mood Stabilizers ................................ ................................ ........................ 551 Chapter 56: Drug Therapy for Psychotic Disorders ................................ ................................ ......................... 560 Chapter 57: Drug Therapy for Attention Deficit Hyperactivity Disorder and Narcolepsy .............................. 569 Chapter 58: Drug Therapy for Substance Use Disorders ................................ ................................ .................. 578 Chapter 59: Drug Therapy for Disorders of the Eye ................................ ................................ ......................... 586 Chapter 60: Drug Therapy for Disorders of the Ear ................................ ................................ ......................... 594 Chapter 61: Drug Therapy for Disorders of the Skin ................................ ................................ ....................... 602 1 | P a g e our Stu rial Chapter 1: The Foundation of Pharmacology: Quality and Safety 1. A woman diagnosed with obsessive–compulsive disorder has been prescribed oral paroxetine hydrochloride. What is the expected effect for this prescription? A. Curative effect on symptoms B. Systemic effect on symptoms C. Local effect on symptoms D. Parenteral effect on symptoms ANS: B Rationale: Drugs that produce systemic effects are taken into the body, circulated through the bloodstream to their sites of action in various body tissues, and eventually eliminated from the body. Curative agents are given to cure a disease process. In this case, paroxetine hydrochloride will control the symptoms but not cure the disorder. Drugs with local effects, such as sunscreen and local anesthetics, act mainly at the site of application. Paroxetine hydrochloride is not administered parenterally. Parenteral agents are administered subcutaneously, intramuscularly, or intravenously. PTS: 1 REF: p. 4 OBJ: 1 NAT: Client Needs: Physiological Integrity: Pharmacological and Parenteral Therapies TOP: Chapter 1: The Foundation of Pharmacology: Quality and Safety KEY: Integrated Process: Nursing Process BLM: Cognitive Level: Understand NOT: Multiple Choice 2. A client has been prescribed an antibiotic. This medication is a naturally occurring substance that has been chemically modified. What is another name for this type of medication? A. Synthetic drug B. Semisynthetic drug C. Biotechnology drug D. Prototype drug ANS: B Rationale: Semisynthetic drugs (e.g., many antibiotics) are naturally occurring substances that have been chemically modified. Synthetic drugs are more standardized in their chemical characteristics, more consistent in their effects, and less likely to produce allergic reactions. Biotechnology drugs involve manipulating DNA and RNA and recombining genes into hybrid molecules that can be inserted into living organisms. Prototype drugs are the first drug of a particular group to be developed. PTS: 1 REF: p. 4 OBJ: 1 NAT: Client Needs: Physiological Integrity: Pharmacological and Parenteral Therapies TOP: Chapter 1: The Foundation of Pharmacology: Quality and Safety KEY: Integrated Process: Nursing Process BLM: Cognitive Level: Understand NOT: Multiple Choice 3. Which classification applies to morphine? A. Central nervous system depressant
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through EFT, credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying this summary from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller beststar. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy this summary for R317,26. You're not tied to anything after your purchase.
